Login
欢迎浏览恩派尔生物资料网
我要投稿 请登录 免费注册 安全退出

  • In Vivo Depletion of FoxP3+ Tregs Using the DEREG Mouse Model

    In Vivo Depletion of FoxP3+ Tregs Using the DEREG Mouse Model

    In recent years, researchers have increasingly focused on the modulation of regu

    2025-07-09 33
  • In Vivo Evaluation of Neutrophil Recruitment in Response to Sterile Particulates

    In Vivo Evaluation of Neutrophil Recruitment in Response to Sterile Particulates

    Sterile particulates such as monosodium urate crystals induce inflammasome activ

    2025-07-09 19
  • In Vivo Method for Establishing Synergy Between Antibodies to Epidermal Growth Factor Receptor and V

    In Vivo Method for Establishing Synergy Between Antibodies to Epidermal Growth Factor Receptor and V

    Targeted therapy for cancer is shifting towards an approach of inhibiting multip

    2025-07-09 18
  • In Vivo Microbial Antigen Discovery (InMAD) to Identify Diagnostic Proteins and Polysaccharides That

    In Vivo Microbial Antigen Discovery (InMAD) to Identify Diagnostic Proteins and Polysaccharides That

    Immunoassays employed at the point-of-care (POC) are often useful for diagnosing

    2025-07-09 24
  • In Vivo Models for Studying Mast Cell-Dependent Responses to Bacterial Infection

    In Vivo Models for Studying Mast Cell-Dependent Responses to Bacterial Infection

    Mast cells are a critical component of host defense against bacterial infections

    2025-07-09 17
  • In Vivo Models for the Study of Transplantation Tolerance

    In Vivo Models for the Study of Transplantation Tolerance

    Experimental models of transplantation remain essential tools for the study of i

    2025-07-09 18
  • In Vivo Models of Inflammation: Immune Rejection and Skin Transplantation In Vivo

    In Vivo Models of Inflammation: Immune Rejection and Skin Transplantation In Vivo

    One of the main functions of the immune system is the recognition and subsequent

    2025-07-09 19
  • In Vivo Models of Inflammation: Introduction to Part 2

    In Vivo Models of Inflammation: Introduction to Part 2

    This section is dedicated to in vivo models of inflammation, a necessary procedu

    2025-07-09 25
  • In Vivo Testing of Anti-HIV Immunotoxins

    In Vivo Testing of Anti-HIV Immunotoxins

    The past several years have seen great optimism resulting from the deployment of

    2025-07-09 23
  • In Vivo Treg Suppression Assays

    In Vivo Treg Suppression Assays

    To fully examine the functionality of a regulatory T cell (Treg ) population, on

    2025-07-09 25
  • In Vivo Visualization of Encephalitic Lesions in Herpes Simplex Virus Type 1 (HSV-1) Infected Mice b

    In Vivo Visualization of Encephalitic Lesions in Herpes Simplex Virus Type 1 (HSV-1) Infected Mice b

    Herpes simplex encephalitis (HSE) is one of the most severe viral infections aff

    2025-07-09 25
  • Incorporation of Immunomodulators into Plasmid DNA Vaccines

    Incorporation of Immunomodulators into Plasmid DNA Vaccines

    The success of candidate vaccines against infectious disease depends on their ab

    2025-07-09 22
  • Indirect ELISA

    Indirect ELISA

    The indirect ELISA is used primarily to determine the strength and/or amount of

    2025-07-09 19
  • Indirect Immunofluorescent Labeling of Fixed Cells

    Indirect Immunofluorescent Labeling of Fixed Cells

    One of the major advantages of flow cytometry is the simultaneous evaluation of

    2025-07-09 23
  • Indirect Immunofluorescent Labeling of Viable Cells

    Indirect Immunofluorescent Labeling of Viable Cells

    The combination of the specificity of the antigen-antibody interaction with the

    2025-07-09 21